Neuroscience

Articles and news from the latest research reports.

Posts tagged brain disorders

90 notes

Funding for better understanding of neural stem cells


A team of scientists led by a researcher from Plymouth University has received funding of more than £400,000 from the Biotechnology and Biological Sciences Research Council (BBSRC) to investigate how neural stem cells differ from each other. The study’s findings could hold the key to the future use of neural stem cells in treatments to eradicate neurological conditions such as dementia and brain tumours.
The research project is a collaborative effort between scientists from Plymouth University Peninsula Schools of Medicine and Biomedical and Healthcare Sciences, the University of Cambridge and the Scripps Research Institute, California USA.
The study will focus on identifying molecular differences between types of neural stem cells. 
Increasing evidence shows that the brain harbours different kinds of neural stem cells. This adds a level of complexity to research investigating the underlying mechanisms and therapies for conditions of the brain and nervous system at a cellular level. 
Neural stem cells are vital to the production of new brain cells, upon which the development and function of the brain depend. Their production is important throughout our adult lives, because tasks such as learning and memory rely on the performance of newly generated adult neurons. In addition, deregulated neural stem cells can turn into cells that initiate brain tumours. 
Worldwide there is an increase in incidences of long-term brain disorders, ranging from dementia to severe depression and cancers of the brain. Such conditions are life devastating and costly, and because the majority of existing therapies treat the symptoms and not the causes of conditions, it is imperative that new and more effective treatments are discovered.
By obtaining a better understanding of how neural stem cells differ from each other and behave, the outcome of this study could provide key information to unlock future potential neural stem-based therapies as a way of supplying well-functioning brain cells, eliminating malfunctioning cells and/or replacing lost cells, offering new hope to patients with neurological conditions.  
The research team will identify and characterise properties specific to different neural stem cells in the living brain, a complicated task given that each kind of stem cell acts in different ways over time and depending on their brain location. To achieve this, the team will work at the outset with neural stem cells from the fruit fly Drosophila, which remarkably shares more than 75 per cent of disease genes with humans. Using this knowledge the team will then take the study forward to mammalian brain models.
The scientist leading the project is Dr. Claudia Barros, lecturer in neuroscience at Plymouth University Peninsula School of Medicine. She said: 

“It is hoped that our work will make a significant contribution to clarify types and number of neural stem cells in the brain and how they operate. By doing so we can better understand the mechanisms they use and look at ways to manipulate those mechanisms. This is very exciting because it can open routes for the future development of superior and targeted neural stem cell-based treatments that could potentially eradicate or reverse diverse neurological conditions. We are very grateful to the BBSRC for its support on this timely and exciting international collaboration”.

Funding for better understanding of neural stem cells

A team of scientists led by a researcher from Plymouth University has received funding of more than £400,000 from the Biotechnology and Biological Sciences Research Council (BBSRC) to investigate how neural stem cells differ from each other. The study’s findings could hold the key to the future use of neural stem cells in treatments to eradicate neurological conditions such as dementia and brain tumours.

The research project is a collaborative effort between scientists from Plymouth University Peninsula Schools of Medicine and Biomedical and Healthcare Sciences, the University of Cambridge and the Scripps Research Institute, California USA.

The study will focus on identifying molecular differences between types of neural stem cells. 

Increasing evidence shows that the brain harbours different kinds of neural stem cells. This adds a level of complexity to research investigating the underlying mechanisms and therapies for conditions of the brain and nervous system at a cellular level. 

Neural stem cells are vital to the production of new brain cells, upon which the development and function of the brain depend. Their production is important throughout our adult lives, because tasks such as learning and memory rely on the performance of newly generated adult neurons. In addition, deregulated neural stem cells can turn into cells that initiate brain tumours. 

Worldwide there is an increase in incidences of long-term brain disorders, ranging from dementia to severe depression and cancers of the brain. Such conditions are life devastating and costly, and because the majority of existing therapies treat the symptoms and not the causes of conditions, it is imperative that new and more effective treatments are discovered.

By obtaining a better understanding of how neural stem cells differ from each other and behave, the outcome of this study could provide key information to unlock future potential neural stem-based therapies as a way of supplying well-functioning brain cells, eliminating malfunctioning cells and/or replacing lost cells, offering new hope to patients with neurological conditions.  

The research team will identify and characterise properties specific to different neural stem cells in the living brain, a complicated task given that each kind of stem cell acts in different ways over time and depending on their brain location. To achieve this, the team will work at the outset with neural stem cells from the fruit fly Drosophila, which remarkably shares more than 75 per cent of disease genes with humans. Using this knowledge the team will then take the study forward to mammalian brain models.

The scientist leading the project is Dr. Claudia Barros, lecturer in neuroscience at Plymouth University Peninsula School of Medicine. She said: 

“It is hoped that our work will make a significant contribution to clarify types and number of neural stem cells in the brain and how they operate. By doing so we can better understand the mechanisms they use and look at ways to manipulate those mechanisms. This is very exciting because it can open routes for the future development of superior and targeted neural stem cell-based treatments that could potentially eradicate or reverse diverse neurological conditions. We are very grateful to the BBSRC for its support on this timely and exciting international collaboration”.

Filed under stem cells brain research brain disorders neuroscience science

216 notes

Gene mutation discovery could explain brain disorders in children
Researchers have discovered that mutations in one of the brain’s key genes could be responsible for impaired mental function in children born with an intellectual disability.
The research, published today in the journal, Human Molecular Genetics, proves that the gene, TUBB5, is essential for a healthy functioning brain.
It’s estimated that intellectual disability affects up to four per cent of people worldwide, and two per cent of all Australians. One of the ways in which intellectual disability occurs is through genetic mutations, which cause problems with normal fetal brain development.  
During fetal brain development, TUBB5 is essential for the proper placement and wiring of new neurons. When the gene is mutated, the brain, which sends and receives messages to the rest of the body, is impaired.
Lead researcher, Dr Julian Heng, from the Australian Regenerative Medicine Institute (ARMI) at Monash University, said genetic mutations to TUBB5 could be responsible for a range of intellectual disabilities. It could also affect the development of basic motor skills such as walking.
“TUBB5 works like a type of scaffolding inside neurons, enabling them to shape their connections to other neurons, so it’s essential for healthy brain development. If the scaffolding is faulty, in this case if TUBB5 mutates, it can have serious consequences,” Dr Heng said.
These new findings build on the team’s collaborative work with researchers in Austria, which led to the discovery of TUBB5 mutations in human brain disorders in 2012. By looking at just three unrelated patients with microcephaly, a rare brain disease in children, the team found striking similarities – each had a mutation to TUBB5. The team also provided the first evidence that the TUBB5 mutations were responsible for each patient’s disorder.
Dr Heng said the research could have important implications, not only for intellectual disabilities but also for a wide range of developmental disorders.
“Learning more about the TUBB5 gene and its mutations could reveal how it shapes the connections of neurons in normal and diseased brain states.
“We’re just at the beginning of this work but if we can understand why and how mutations occur to TUBB5, we may even be able to repair these mutations. In the future, we believe this work will enable us to develop new therapies to transform people’s lives,” Dr Heng said.
The work may potentially lead to new information about the causes and possible treatments for other brain developmental syndromes, including autism, a condition that affects as many as 1 in 160 children.
Dr Heng said that because TUBB5 belongs to a family of genes which produce the scaffolding in neurons, it means that there is scope for further study into its impact.
“By learning what these scaffolding proteins do to help neurons make brain circuits, we might be able to pinpoint the underlying causes of a wide range of brain disorders in children, and develop more targeted treatments,” Dr Heng said.
Scientists believe that in the future this knowledge, combined with regenerative medicine techniques, could also aid the replacement of neurons in times of brain injury or disease.
The next phase of the research will be to develop a working model to better understand how TUBB5 can be targeted for gene therapy.

Gene mutation discovery could explain brain disorders in children

Researchers have discovered that mutations in one of the brain’s key genes could be responsible for impaired mental function in children born with an intellectual disability.

The research, published today in the journal, Human Molecular Genetics, proves that the gene, TUBB5, is essential for a healthy functioning brain.

It’s estimated that intellectual disability affects up to four per cent of people worldwide, and two per cent of all Australians. One of the ways in which intellectual disability occurs is through genetic mutations, which cause problems with normal fetal brain development.  

During fetal brain development, TUBB5 is essential for the proper placement and wiring of new neurons. When the gene is mutated, the brain, which sends and receives messages to the rest of the body, is impaired.

Lead researcher, Dr Julian Heng, from the Australian Regenerative Medicine Institute (ARMI) at Monash University, said genetic mutations to TUBB5 could be responsible for a range of intellectual disabilities. It could also affect the development of basic motor skills such as walking.

“TUBB5 works like a type of scaffolding inside neurons, enabling them to shape their connections to other neurons, so it’s essential for healthy brain development. If the scaffolding is faulty, in this case if TUBB5 mutates, it can have serious consequences,” Dr Heng said.

These new findings build on the team’s collaborative work with researchers in Austria, which led to the discovery of TUBB5 mutations in human brain disorders in 2012. By looking at just three unrelated patients with microcephaly, a rare brain disease in children, the team found striking similarities – each had a mutation to TUBB5. The team also provided the first evidence that the TUBB5 mutations were responsible for each patient’s disorder.

Dr Heng said the research could have important implications, not only for intellectual disabilities but also for a wide range of developmental disorders.

“Learning more about the TUBB5 gene and its mutations could reveal how it shapes the connections of neurons in normal and diseased brain states.

“We’re just at the beginning of this work but if we can understand why and how mutations occur to TUBB5, we may even be able to repair these mutations. In the future, we believe this work will enable us to develop new therapies to transform people’s lives,” Dr Heng said.

The work may potentially lead to new information about the causes and possible treatments for other brain developmental syndromes, including autism, a condition that affects as many as 1 in 160 children.

Dr Heng said that because TUBB5 belongs to a family of genes which produce the scaffolding in neurons, it means that there is scope for further study into its impact.

“By learning what these scaffolding proteins do to help neurons make brain circuits, we might be able to pinpoint the underlying causes of a wide range of brain disorders in children, and develop more targeted treatments,” Dr Heng said.

Scientists believe that in the future this knowledge, combined with regenerative medicine techniques, could also aid the replacement of neurons in times of brain injury or disease.

The next phase of the research will be to develop a working model to better understand how TUBB5 can be targeted for gene therapy.

Filed under children TUBB5 brain disorders neurons genetics neuroscience science

282 notes

Stem cells from teeth can make brain-like cells
University of Adelaide researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke.
In the University’s Centre for Stem Cell Research, laboratory studies have shown that stem cells from teeth can develop and form complex networks of brain-like cells. Although these cells haven’t developed into fully fledged neurons, researchers believe it’s just a matter of time and the right conditions for it to happen.
"Stem cells from teeth have great potential to grow into new brain or nerve cells, and this could potentially assist with treatments of brain disorders, such as stroke," says Dr Kylie Ellis, Commercial Development Manager with the University’s commercial arm, Adelaide Research & Innovation (ARI).
Dr Ellis conducted this research as part of her Physiology PhD studies at the University, before making the step into commercialisation. The results of her work have been published in the journal Stem Cell Research & Therapy.
"The reality is, treatment options available to the thousands of stroke patients every year are limited," Dr Ellis says. "The primary drug treatment available must be administered within hours of a stroke and many people don’t have access within that timeframe, because they often can’t seek help for some time after the attack.
"Ultimately, we want to be able to use a patient’s own stem cells for tailor-made brain therapy that doesn’t have the host rejection issues commonly associated with cell-based therapies. Another advantage is that dental pulp stem cell therapy may provide a treatment option available months or even years after the stroke has occurred," she says.
Dr Ellis and her colleagues, Professors Simon Koblar, David O’Carroll and Stan Gronthos, have been working on a laboratory-based model for actual treatment in humans. As part of this research Dr Ellis found that stem cells derived from teeth developed into cells that closely resembled neurons.
"We can do this by providing an environment for the cells that is as close to a normal brain environment as possible, so that instead of becoming cells for teeth they become brain cells," Dr Ellis says.
"What we developed wasn’t identical to normal neurons, but the new cells shared very similar properties to neurons. They also formed complex networks and communicated through simple electrical activity, like you might see between cells in the developing brain."
This work with dental pulp stem cells opens up the potential for modelling many more common brain disorders in the laboratory, which could help in developing new treatments and techniques for patients.

Stem cells from teeth can make brain-like cells

University of Adelaide researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke.

In the University’s Centre for Stem Cell Research, laboratory studies have shown that stem cells from teeth can develop and form complex networks of brain-like cells. Although these cells haven’t developed into fully fledged neurons, researchers believe it’s just a matter of time and the right conditions for it to happen.

"Stem cells from teeth have great potential to grow into new brain or nerve cells, and this could potentially assist with treatments of brain disorders, such as stroke," says Dr Kylie Ellis, Commercial Development Manager with the University’s commercial arm, Adelaide Research & Innovation (ARI).

Dr Ellis conducted this research as part of her Physiology PhD studies at the University, before making the step into commercialisation. The results of her work have been published in the journal Stem Cell Research & Therapy.

"The reality is, treatment options available to the thousands of stroke patients every year are limited," Dr Ellis says. "The primary drug treatment available must be administered within hours of a stroke and many people don’t have access within that timeframe, because they often can’t seek help for some time after the attack.

"Ultimately, we want to be able to use a patient’s own stem cells for tailor-made brain therapy that doesn’t have the host rejection issues commonly associated with cell-based therapies. Another advantage is that dental pulp stem cell therapy may provide a treatment option available months or even years after the stroke has occurred," she says.

Dr Ellis and her colleagues, Professors Simon Koblar, David O’Carroll and Stan Gronthos, have been working on a laboratory-based model for actual treatment in humans. As part of this research Dr Ellis found that stem cells derived from teeth developed into cells that closely resembled neurons.

"We can do this by providing an environment for the cells that is as close to a normal brain environment as possible, so that instead of becoming cells for teeth they become brain cells," Dr Ellis says.

"What we developed wasn’t identical to normal neurons, but the new cells shared very similar properties to neurons. They also formed complex networks and communicated through simple electrical activity, like you might see between cells in the developing brain."

This work with dental pulp stem cells opens up the potential for modelling many more common brain disorders in the laboratory, which could help in developing new treatments and techniques for patients.

Filed under stem cells brain cells teeth stroke brain disorders neuroscience science

124 notes

Children’s Brain Imaging Data Bank Could Become a ‘Google’ Tool for Doctors

When an MRI scan uncovers an unusual architecture or shape in a child’s brain, it’s cause for concern: The malformation may be a sign of disease. But deciding whether that odd-looking anatomy is worrisome or harmless can be difficult. To help doctors reach the right decision, Johns Hopkins researchers are building a detailed digital library of MRI scans collected from children with normal and abnormal brains. The goal, the researchers say, is to give physicians a Google-like search system that will enhance the way they diagnose and treat young patients with brain disorders.

This cloud-computing project, being developed by a team of engineers and radiologists, should allow physicians to access thousands of pediatric scans to look for some that resemble their own patient’s image. The project is supported by a three-year $600,000 grant from the National Institutes of Health.

"We’re creating a pediatric brain data bank that will let doctors look at MRI brain scans of children who have already been diagnosed with illnesses like epilepsy or psychiatric disorders," said Michael I. Miller, a lead investigator on the project. "It will provide a way to share important new discoveries about how changes in brain structures are linked to brain disorders. For the medical imaging world, this system will do what a search engine like Google does when you ask it to look for specific information on the Web."

Miller, a pioneer in the field of computational anatomy, the technology used for “brain parsing,” is the Herschel and Ruth Seder Professor of Biomedical Engineering at Johns Hopkins and director of the university’s Center for Imaging Science. He also is a core faculty member in the university’s Institute for Computational Medicine.

The new pediatric brain imaging data bank, Miller said, will be useful in at least two ways.

"If doctors aren’t sure which disease is causing a child’s condition, they could search the data bank for images that closely match their patient’s most recent scan," he said. "If a diagnosis is already attached to an image from the data bank that could steer the physician in the right direction. Also, the scans in our library may help a physician identify a change in the shape of a brain structure that occurs very early in the course of a disease, even before clinical symptoms appear. That could allow the physician get an early start on the treatment."

Miller’s co-lead investigator on the project is Susumu Mori, a professor of radiology in the Johns Hopkins School of Medicine. One of Mori’s primary research interests is studying the anatomy of brain structures captured in MRI scans. 

Mori points out that such a “biobank” has the potential to impact doctors’ workflow dramatically.

"We empirically know that a certain type of anatomical abnormality is related to specific brain diseases," he said. "This relationship, however, is not always clear and often is compounded by anatomical changes during the normal course of brain development. Therefore, neuro-radiologists need extensive training to accumulate the knowledge. We hope our brain imaging data bank will not only assist such a learning process but also enhance the physician’s ability to understand the pathology and reach the best medical decision."

Mori and his collaborator, Thierry Huisman, a professor of radiology and pediatrics and the director of pediatric radiology at the Johns Hopkins Children’s Center, have been working for more than four years to establish a clinical database of more than 5,000 whole-brain MRI scans of children treated at Johns Hopkins. The patients’ names and other identifying information were withheld, but details related to their medical conditions were included. The computer software indexed anatomical information involving up to 1,000 structural measurements in 250 regions of the brain. These images were also sorted into 22 brain disease categories, including chromosomal abnormalities, congenital malformations, vascular diseases, infections, epilepsy and psychiatric disorders.

According to Huisman, the new data bank now under development not only facilitates recognition and correct classification of pediatric brain disorders, but the more objective image analysis also allows identification of injury and disease that may go undetected by the classical, more subjective radiological “eyeballing” of MR images. Furthermore, he said, recognition of distinct patterns of injury and the subsequent grouping of these children based upon their characteristic patterns of MRI findings allow recognition and identification of new diseases as well as reclassification of previously unclassified diseases. Finally, he added, the data acquisition is free of ionizing radiation, allowing doctors to study the most vulnerable, youngest patients and perhaps to help initiate disease-specific treatment before irreversible injury to the developing brain occurs.

Beyond the brain imaging data bank for children, the researchers have begun building a similar MRI brain image library with Marilyn Albert, a Johns Hopkins neurology professor. This library focuses on brain disorders commonly found in elderly patients. That project is associated with the National Institute of Aging’ Alzheimer’s Disease Research Center.

With all of this data in place, physicians will be able to conduct a Google-like search for images associated with normal and abnormal pediatric and aging brain conditions. For example, a physician who is uncertain about a child’s diagnosis could submit that patient’s latest brain scan and request the medical records of children with similar images. Alternatively, for studying neurodegenerative diseases such as Alzheimer’s in aging patients, a physician might ask to see the medical records associated with all images that display neurofibrillary tangles in the temporal lobe, a condition seen in his or her patient’s scan.

Jonathan Lewin, the chairman and radiologist-in-chief of the Johns Hopkins Department of Radiology and Radiological Science, noted that this approach could help patients with both common and uncommon diseases. “This research is one of the first real applications of ‘Big Data’ analytics, taking medical information from large numbers of patients, removing anything that would identify specific individuals, and then bringing the data into the ‘cloud’ to allow very high-powered analysis,” Lewin said. “This has been a goal of the medical community for almost a decade, and professors Miller and Mori have found a way to implement this technology in a manner that can bring its benefit to our patients, and can assist in the classification and identification of rare and subtle brain disorders as well as uncommon manifestations of more common diseases of the brain.”

Currently, the pilot pediatric brain imaging data bank is limited to physicians and patients within the Johns Hopkins medical system, but the researchers say the data bank could be expanded or replicated elsewhere in coming years.

(Source: hopkinschildrens.org)

Filed under MRI scans brain disorders brain data bank brain imaging neuroscience science

187 notes

Human Connectome Project releases major data set on brain connectivity
The Human Connectome Project, a five-year endeavor to link brain connectivity to human behavior, has released a set of high-quality imaging and behavioral data to the scientific community. The project has two major goals: to collect vast amounts of data using advanced brain imaging methods on a large population of healthy adults, and to make the data freely available so that scientists worldwide can make further discoveries about brain circuitry.
The initial data release includes brain imaging scans plus behavioral information — individual differences in personality, cognitive capabilities, emotional characteristics and perceptual function — obtained from 68 healthy adult volunteers. Over the next several years, the number of subjects studied will increase steadily to a final target of 1,200. The initial release is an important milestone because the new data have much higher resolution in space and time than data obtained by conventional brain scans.
The Human Connectome Project (HCP) consortium is led by David C. Van Essen, PhD, Alumni Endowed Professor at Washington University School of Medicine in St. Louis, and Kamil Ugurbil, PhD, Director of the Center for Magnetic Resonance Research and the McKnight Presidential Endowed Chair Professor at the University of Minnesota.
“By making this unique data set available now, and continuing with regular data releases every quarter, the Human Connectome Project is enabling the scientific community to immediately begin exploring relationships between brain circuits and individual behavior,” says Van Essen. “The HCP will have a major impact on our understanding of the healthy adult human brain, and it will set the stage for future projects that examine changes in brain circuits underlying the wide variety of brain disorders afflicting humankind.”
The consortium includes more than 100 investigators and technical staff at 10 institutions in the United States and Europe (www.humanconnectome.org). It is funded by 16 components of the National Institutes of Health via the Blueprint for Neuroscience Research (www.neuroscienceblueprint.nih.gov).
“The high quality of the data being made available in this release reflects an intensive, multiyear effort to improve the data acquisition and analysis methods by this dedicated international team of investigators,” says Ugurbil.
The data set includes information about brain connectivity in each individual, using two distinct magnetic resonance imaging (MRI) approaches. One, called resting-state functional connectivity, is based on spontaneous fluctuations in functional MRI signals that occur in a complex pattern in space and time throughout the gray matter of the brain. Another, called diffusion imaging, provides information about the long-distance “wiring” – the anatomical pathways traversing the brain’s white matter. Each method has its own limitations, and analyses of both functional connectivity and structural connectivity in each subject should allow deeper insight than by either method alone.
Each subject is also scanned while performing a variety of tasks within the scanner, thereby providing extensive information about “Task-fMRI” brain activation patterns. Behavioral data using a variety of tests performed outside the scanner are being released along with the scan data for each subject. The subjects are drawn from families that include siblings, some of whom are twins. This will enable studies of the heritability of brain circuits.
The imaging data set released by the HCP takes up about two terabytes (2 trillion bytes) of computer memory — the equivalent of more than 400 DVDs — and is stored in a customized database called “ConnectomeDB.”
“ConnectomeDB is the next-generation neuroinformatics software for data sharing and data mining. It’s a convenient and user-friendly way for scientists to explore the available HCP data and to download data of interest for their research,” says Daniel S. Marcus, PhD, assistant professor of radiology and director of the Neuroinformatics Research Group at Washington University School of Medicine. “The Human Connectome Project represents a major advance in sharing brain imaging data in ways that will accelerate the pace of discovery about the human brain in health and disease.”

Human Connectome Project releases major data set on brain connectivity

The Human Connectome Project, a five-year endeavor to link brain connectivity to human behavior, has released a set of high-quality imaging and behavioral data to the scientific community. The project has two major goals: to collect vast amounts of data using advanced brain imaging methods on a large population of healthy adults, and to make the data freely available so that scientists worldwide can make further discoveries about brain circuitry.

The initial data release includes brain imaging scans plus behavioral information — individual differences in personality, cognitive capabilities, emotional characteristics and perceptual function — obtained from 68 healthy adult volunteers. Over the next several years, the number of subjects studied will increase steadily to a final target of 1,200. The initial release is an important milestone because the new data have much higher resolution in space and time than data obtained by conventional brain scans.

The Human Connectome Project (HCP) consortium is led by David C. Van Essen, PhD, Alumni Endowed Professor at Washington University School of Medicine in St. Louis, and Kamil Ugurbil, PhD, Director of the Center for Magnetic Resonance Research and the McKnight Presidential Endowed Chair Professor at the University of Minnesota.

“By making this unique data set available now, and continuing with regular data releases every quarter, the Human Connectome Project is enabling the scientific community to immediately begin exploring relationships between brain circuits and individual behavior,” says Van Essen. “The HCP will have a major impact on our understanding of the healthy adult human brain, and it will set the stage for future projects that examine changes in brain circuits underlying the wide variety of brain disorders afflicting humankind.”

The consortium includes more than 100 investigators and technical staff at 10 institutions in the United States and Europe (www.humanconnectome.org). It is funded by 16 components of the National Institutes of Health via the Blueprint for Neuroscience Research (www.neuroscienceblueprint.nih.gov).

“The high quality of the data being made available in this release reflects an intensive, multiyear effort to improve the data acquisition and analysis methods by this dedicated international team of investigators,” says Ugurbil.

The data set includes information about brain connectivity in each individual, using two distinct magnetic resonance imaging (MRI) approaches. One, called resting-state functional connectivity, is based on spontaneous fluctuations in functional MRI signals that occur in a complex pattern in space and time throughout the gray matter of the brain. Another, called diffusion imaging, provides information about the long-distance “wiring” – the anatomical pathways traversing the brain’s white matter. Each method has its own limitations, and analyses of both functional connectivity and structural connectivity in each subject should allow deeper insight than by either method alone.

Each subject is also scanned while performing a variety of tasks within the scanner, thereby providing extensive information about “Task-fMRI” brain activation patterns. Behavioral data using a variety of tests performed outside the scanner are being released along with the scan data for each subject. The subjects are drawn from families that include siblings, some of whom are twins. This will enable studies of the heritability of brain circuits.

The imaging data set released by the HCP takes up about two terabytes (2 trillion bytes) of computer memory — the equivalent of more than 400 DVDs — and is stored in a customized database called “ConnectomeDB.”

“ConnectomeDB is the next-generation neuroinformatics software for data sharing and data mining. It’s a convenient and user-friendly way for scientists to explore the available HCP data and to download data of interest for their research,” says Daniel S. Marcus, PhD, assistant professor of radiology and director of the Neuroinformatics Research Group at Washington University School of Medicine. “The Human Connectome Project represents a major advance in sharing brain imaging data in ways that will accelerate the pace of discovery about the human brain in health and disease.”

Filed under brain circuitry brain imaging Human Connectome Project connectome brain disorders neuroscience science

52 notes

Cell discovery could hold key to causes of inherited diseases

Fresh insights into the protective seal that surrounds the DNA of our cells could help develop treatments for inherited muscle, brain, bone and skin disorders.

Researchers have discovered that the proteins within this coating – known as the nuclear envelope – vary greatly between cells in different organs of the body.

This variation means that certain disease causing proteins will interact with the proteins in the protective seal to cause illness in some organs, but not others.

Until now scientists had thought that all proteins within the nuclear envelope were the same in every type of organ.

In particular the finding may provide insights into a rare muscle disease, Emery-Dreifuss muscular dystrophy.

This condition causes muscle wastage and heart problems, affects only muscles, even though it is caused by a defect in a nuclear envelope protein found in every cell in the body.

Scientists say that the envelope proteins they have identified as being specific to muscle may interact with the defective nuclear envelope protein that causes Emery-Dreifuss muscular dystrophy, to give rise to the disease.

In a similar way, this may help to explain other heritable diseases that only affect certain parts of the body despite the defective proteins being present in every cell. The study also identified nuclear envelope proteins specific to liver and blood.

Some of these also interact with proteins in all cells that are responsible for other nuclear envelope diseases, ranging from brain and fat to skin diseases, and so may help explain why things go wrong.

Dr Eric Schirmer, of the University of Edinburgh’s Wellcome Trust Centre for Cell Biology, who led the study said: “Nobody could have imagined what we found.

The fact that most proteins in the nuclear envelope would be specific for certain tissue types is a very exciting development. This may finally enable us to understand this ever-growing spectrum of inherited diseases as well as new aspects of tissue-specific gene regulation.”

The findings build on previous research that showed proteins in the nuclear envelope are linked to more than 20 heritable diseases.

(Source: eurekalert.org)

Filed under muscular dystrophy envelope protein brain disorders inherited diseases medicine science

136 notes






New Research on How the Brain Makes Decisions
Neuroscience researchers at Trinity College Dublin have opened a new avenue for research on how the brain enables us to make decisions about our environment. By observing the gradual formation of a decision in brain activity before the particular decision was actually reported, the findings also have the potential to contribute to improved understanding and diagnosis of numerous brain disorders that are associated with impaired perceptual decision making. The discovery was recently published in Nature Neuroscience.
When interacting with our environment, we need to be sure about what we’re seeing, feeling or hearing in order to decide how to act. What does that road sign ahead say? Is that a train I hear approaching? Is it too dark for me to cycle home without a light? Somehow the brain enables us to make concrete decisions about the vast and often unreliable array of information it continually receives through the senses. One influential theory about how this might be achieved proposes that the brain allows information from the senses to accumulate over time and only commits to a particular decision once a reliable quantity has been gathered. While this theory has existed for several decades Assistant Professor, Redmond O’Connell at the Trinity College Institute of Neuroscience and colleagues are the first to have identified exactly how this occurs in the human brain.
The researchers designed a new test which required participants to detect a gradual change in a visual display or an auditory tone. The gradual change occurred over several seconds and was undetectable at first but eventually became obvious. This allowed the researchers to pinpoint the precise moment at which participants decided that a change had occurred. At the same time, the researchers recorded brain activity using electrodes placed on the scalp. Using this method the authors succeeded in isolating a brain signal that increased in parallel with the visual or auditory change and continued to increase thereafter. Most importantly, the authors found that participants only reported perceiving the change once this signal had reached a certain level. As a result, it was possible to precisely predict both the timing and accuracy of the participant’s decisions simply by monitoring this brain signal. In other words, it was possible to observe the gradual formation of a decision in the participant’s brain activity before that decision was actually reported.

New Research on How the Brain Makes Decisions

Neuroscience researchers at Trinity College Dublin have opened a new avenue for research on how the brain enables us to make decisions about our environment. By observing the gradual formation of a decision in brain activity before the particular decision was actually reported, the findings also have the potential to contribute to improved understanding and diagnosis of numerous brain disorders that are associated with impaired perceptual decision making. The discovery was recently published in Nature Neuroscience.

When interacting with our environment, we need to be sure about what we’re seeing, feeling or hearing in order to decide how to act. What does that road sign ahead say? Is that a train I hear approaching? Is it too dark for me to cycle home without a light? Somehow the brain enables us to make concrete decisions about the vast and often unreliable array of information it continually receives through the senses. One influential theory about how this might be achieved proposes that the brain allows information from the senses to accumulate over time and only commits to a particular decision once a reliable quantity has been gathered. While this theory has existed for several decades Assistant Professor, Redmond O’Connell at the Trinity College Institute of Neuroscience and colleagues are the first to have identified exactly how this occurs in the human brain.

The researchers designed a new test which required participants to detect a gradual change in a visual display or an auditory tone. The gradual change occurred over several seconds and was undetectable at first but eventually became obvious. This allowed the researchers to pinpoint the precise moment at which participants decided that a change had occurred. At the same time, the researchers recorded brain activity using electrodes placed on the scalp. Using this method the authors succeeded in isolating a brain signal that increased in parallel with the visual or auditory change and continued to increase thereafter. Most importantly, the authors found that participants only reported perceiving the change once this signal had reached a certain level. As a result, it was possible to precisely predict both the timing and accuracy of the participant’s decisions simply by monitoring this brain signal. In other words, it was possible to observe the gradual formation of a decision in the participant’s brain activity before that decision was actually reported.

Filed under brain brain activity brain disorders decision-making neuroscience science

60 notes

The eyes may be windows into the soul, but following their movement also could allow doctors to make quick, accurate diagnoses for disorders like autism, schizophrenia, or attention deficit hyperactivity disorder, various research projects suggest.
Eye tracking, which records where subjects focus when watching visual displays, could diagnose brain disorders more accurately than subjective questionnaires or medical examinations do, researchers say. Exams are expensive and time-consuming, and subjective tests have been known to wrongly identify healthy people or misdiagnose disorders.
To make sense of all that people see, the brain filters huge amounts of visual information, fills in gaps and focuses on certain objects. That complex task uses many mental circuits, so differences in what people choose to look at ― differences so subtle that only a computer can spot them ― could provide unprecedented insight into common neurological problems.

The eyes may be windows into the soul, but following their movement also could allow doctors to make quick, accurate diagnoses for disorders like autism, schizophrenia, or attention deficit hyperactivity disorder, various research projects suggest.

Eye tracking, which records where subjects focus when watching visual displays, could diagnose brain disorders more accurately than subjective questionnaires or medical examinations do, researchers say. Exams are expensive and time-consuming, and subjective tests have been known to wrongly identify healthy people or misdiagnose disorders.

To make sense of all that people see, the brain filters huge amounts of visual information, fills in gaps and focuses on certain objects. That complex task uses many mental circuits, so differences in what people choose to look at ― differences so subtle that only a computer can spot them ― could provide unprecedented insight into common neurological problems.

Filed under ADHD autism brain brain disorders disorders eye movements eye tracking neuroscience psychology schizophrenia vision science

free counters